APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1
about
Prototype foamy virus Bet impairs the dimerization and cytosolic solubility of human APOBEC3GMolecular Studies of HTLV-1 Replication: An UpdateModes of Human T Cell Leukemia Virus Type 1 Transmission, Replication and PersistenceNMR structure of human restriction factor APOBEC3A reveals substrate binding and enzyme specificityA DNA sequence recognition loop on APOBEC3A controls substrate specificityInteraction of APOBEC3A with DNA assessed by atomic force microscopyTransient overexpression of exogenous APOBEC3A causes C-to-U RNA editing of thousands of genes.Different modes of retrovirus restriction by human APOBEC3A and APOBEC3G in vivo.A conflict of interest: the evolutionary arms race between mammalian APOBEC3 and lentiviral Vif.Vif Proteins from Diverse Human Immunodeficiency Virus/Simian Immunodeficiency Virus Lineages Have Distinct Binding Sites in A3C.Human papillomavirus E6 triggers upregulation of the antiviral and cancer genomic DNA deaminase APOBEC3BHuman APOBEC3A isoforms translocate to the nucleus and induce DNA double strand breaks leading to cell stress and death.Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral DNA accumulationSequence and structural determinants of human APOBEC3H deaminase and anti-HIV-1 activities.Lack of association between intact/deletion polymorphisms of the APOBEC3B gene and HIV-1 riskAPOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophagesThe RNA Binding Specificity of Human APOBEC3 Proteins Resembles That of HIV-1 NucleocapsidRetroelements versus APOBEC3 family members: No great escape from the magnificent sevenThe Tax-Inducible Actin-Bundling Protein Fascin Is Crucial for Release and Cell-to-Cell Transmission of Human T-Cell Leukemia Virus Type 1 (HTLV-1).DNA cytosine and methylcytosine deamination by APOBEC3B: enhancing methylcytosine deamination by engineering APOBEC3B.Identification of the HIV-1 Vif and Human APOBEC3G Protein Interface.Murine leukemia virus glycosylated Gag blocks apolipoprotein B editing complex 3 and cytosolic sensor access to the reverse transcription complex.Endogenous APOBEC3A DNA cytosine deaminase is cytoplasmic and nongenotoxic.Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity.Role of the host restriction factor APOBEC3 on papillomavirus evolutionA biochemical analysis linking APOBEC3A to disparate HIV-1 restriction and skin cancerThe local dinucleotide preference of APOBEC3G can be altered from 5'-CC to 5'-TC by a single amino acid substitution.The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis.Structural determinants of human APOBEC3A enzymatic and nucleic acid binding properties.APOBECs and virus restriction.Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer.Functions and Malfunctions of Mammalian DNA-Cytosine DeaminasesA prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3'UTR enhances chromosomal DNA damage.Cellular HIV-1 inhibition by truncated old world primate APOBEC3A proteins lacking a complete deaminase domain.The Structural Interface between HIV-1 Vif and Human APOBEC3H.Lentivirus restriction by diverse primate APOBEC3A proteins.In Vivo Examination of Mouse APOBEC3- and Human APOBEC3A- and APOBEC3G-Mediated Restriction of Parvovirus and Herpesvirus Infection in Mouse Models.APOBEC3B lysine residues are dispensable for DNA cytosine deamination, HIV-1 restriction, and nuclear localization.Conservation and Innovation of APOBEC3A Restriction Functions during Primate Evolution.The role of cytidine deaminases on innate immune responses against human viral infections.
P2860
Q24629953-698406C3-9076-4C9E-B8ED-1A5C8C6E9E24Q26772930-80924C68-E1FC-40FE-9B91-E4F78D98D332Q26801294-F1412CBD-817A-430E-97EF-E2DD0F45FA37Q27678249-356ED8D9-F232-4293-9C6B-129684DC29F5Q28538801-F50FC178-ED4F-4099-BC91-19A49B1F5524Q28539478-A5CC9105-31A9-4CA3-9103-B1ADE98F34D3Q30853937-58F31E35-6371-4263-B195-F0CE8BA9C5B4Q33650603-A38E0712-4174-42D3-98FA-1B55AE12A424Q33651576-168B534B-A369-40A5-9DBC-11293507A854Q34539110-004BAA8C-237E-4461-897A-A03ACBA5F5DEQ34782173-35D7F6DC-C6DF-4043-B632-9007C43DD16FQ34974240-2F402E46-0D4C-41BA-A920-2D2ABECD0089Q35041156-00D9D979-75DE-489E-BBEB-5EAB771635FAQ35068754-7981C462-9D49-49E4-94F3-D119E74457ADQ35131366-D12CC907-8812-4DB2-88E9-2FBE532BEF39Q35543248-74602C2D-FCDF-4842-926E-574A56C95C31Q36107814-C72A58FB-4AE3-4CCE-BA29-1A8288B9C6E8Q36162443-90C90302-8590-41CD-BD02-DE1E007539C8Q36173231-6EC54CB5-92E9-4961-99DB-9ADE6A7475C3Q36184715-55770FB2-E899-4E9F-8969-3BA0F87A7EE1Q36348886-CA5F5BE6-6717-4EF9-8B4D-D61426490875Q36895829-269B5F0A-BD0C-4FCD-BB58-D09A4053C6AFQ36928973-7027682F-225D-4931-9464-F7CD968FC1B8Q37091342-9431C742-D65E-49E8-A707-FD6908E93055Q37207674-607A3A38-F4D5-4B4B-9387-433B60B6FB75Q37226085-9E4890A6-1305-41F2-97D9-8BEB3C348310Q37265843-332D8A87-90EF-45F3-9FB5-4D5F31595F0EQ37281847-148B9597-C2EC-417B-BB9E-1A05913693B2Q37518666-9D2C11DB-590C-4661-8724-D40FC8A4E6AFQ38394187-504197DB-4DB7-4C32-826E-1EDF905F238DQ38613375-46281901-9ECB-4505-8332-DCFA4B7CB5F5Q38943944-7627C412-1108-45B5-BD95-05BE6ECC6812Q38949554-16144425-2E39-4180-8066-6F3557C8A01BQ38952694-E3D5CF1F-0332-479D-B1E3-72A142169C7DQ39056653-4E75A9A2-D2CC-4CD2-998B-894A4F8770CAQ39155683-10AFF200-CC43-4370-884C-94847B9FAF63Q39645012-C78FF71A-87B1-4FA0-BEE0-0F2238CA255EQ40070390-FB2D7F11-E83D-44CD-A44B-4AD5025A73B8Q41006917-869BE22F-D848-47A1-A5D1-D86F053BE112Q41812539-37FC779F-E378-49E1-B9D6-32DDF8BCC8A3
P2860
APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1
@ast
APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1
@en
APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1
@en-gb
APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1
@nl
type
label
APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1
@ast
APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1
@en
APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1
@en-gb
APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1
@nl
prefLabel
APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1
@ast
APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1
@en
APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1
@en-gb
APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1
@nl
P2860
P50
P921
P3181
P356
P1433
P1476
APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1
@en
P2093
Aikaterini Krikoni
Carsten Münk
P2860
P304
P3181
P356
10.1128/JVI.06570-11
P407
P577
2012-06-01T00:00:00Z